Skip to Main Content

1,479

Views

2

CrossRef citations to date

0

Altmetric

Short Report

Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized study

Yuemei HuVaccine Clinical Evaluation Department, Jiangsu Center for Disease Prevention and Control, Nanjing, ChinaView further author information

,

Kai ChuVaccine Clinical Evaluation Department, Jiangsu Center for Disease Prevention and Control, Nanjing, ChinaView further author information

,

Nathalie LavisMedical Operations, Sanofi Pasteur, Lyon, FranceCorrespondence[email protected]
View further author information

,

Xiaoling LiMedical Operations, Sanofi Pasteur, Beijing, ChinaView further author information

,

Bill LiangMedical Department, Sanofi Pasteur, Beijing, ChinaView further author information

,

Shuzhen LiuDivision of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, ChinaView further author information

,

Ming ShaoDivision of Respiratory Virus Vaccines, National Institutes for Food and Drug Control, Beijing, ChinaView further author information

,

Jean-Denis ShuMedical Department, Sanofi Pasteur, Lyon, FranceView further author information

,

Cynthia TabarClinical Operations, Sanofi Pasteur, Lyon, FranceView further author information

&

Sandrine SamsonGlobal Medical, Sanofi Pasteur, Swiftwater, PA, USAView further author information